H&R GmbH KGaA (LTS:0RRC) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RRC H&R GmbH & Co KGaA LTS:0RRC
66 GF Score
Price €6.10
GF Value €4.15
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is H&R GmbH KGaA Net Loan?

Net Loan only applies to banks and insurance companies.

LTS:0RRC
66GF Score
H&R GmbH & Co KGaA LTS:0RRC
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is H&R GmbH KGaA (LTS:0RRC) Overvalued in 2026?

Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued. The current stock price of €6.10 is trading 47% above its estimated GF Value™ of €4.15. GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.

Key valuation signals for LTS:0RRC:

  • Net Loan:
  • GF Value™: €4.15 vs. price of €6.10 (47% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the LTS:0RRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


H&R GmbH KGaA Business Description

Other Exchanges 2HRA:Germany2HRA:Austria
Address Neuenkirchener Strasse 8, Salzbergen, NI, DEU, 48499
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
66GF Score

Get the complete analysis for LTS:0RRC

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.10
Price
€4.15
GF Value